Dendreon
BioTech/Drugs - Seal Beach, California, US
Dendreon Details
Dendreon is a commercial-stage biopharmaceutical company and pioneer in the development of immunotherapy. Dendreon’s flagship product, PROVENGE (sipuleucel-T), was the first FDA-approved immunotherapy made from a patient’s own immune cells. More than 40,000 men with advanced prostate cancer have been prescribed PROVENGE in the U.S. since 2010. Dendreon also is evaluating the use of PROVENGE in early-stage prostate cancer, with the hope of curing more men of the disease. Dendreon is headquartered in Seal Beach, Calif.
Website:
http://www.dendreon.com
Employees:
609
HQ:
(877) 256-4545
Location:
Seal Beach, California, US
Revenue:
$238.4 million
Dendreon Technologies
Email Providers
Outlook
Customer Relationship Management
Salesforce
Domain Name Services
CSC Corporate Domains
Other
Microsoft Office 365